WAYLIVRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Jul 2022)
What this means for you
This application is over — abandoned 25 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90001500
- Mark type
- Stylized text
- Filed
- 15 Jun 2020
- Published for opposition
- 27 Oct 2020
- Abandoned
- 25 Jul 2022
- Attorney of record
- Anne H. Peck
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and human therapeutic preparations and agents for treating and preventing lipid diseases and conditions, cardiometabolic diseases and conditions, and pancreatitis; pharmaceutical preparations and human therapeutic preparations and agents for lowering protein apoc3 and triglyceride levels in blood, controlling blood glucose, and reducing abdominal pain and pancreatic inflammation; antisense oligonucleotides for medical purposes; injectable pharmaceuticals for metabolic diseases and conditions
Owner
- Akcea Therapeutics, Inc., Boston, MA, US
- Akcea Therapeutics, Inc., Boston, MA, US
Prosecution history
- 25 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2021 — SOU EXTENSION 2 GRANTED
- 08 Dec 2021 — SOU EXTENSION 2 FILED
- 08 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2021 — SOU EXTENSION 1 GRANTED
- 07 Jun 2021 — SOU EXTENSION 1 FILED
- 07 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Dec 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Oct 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Oct 2020 — PUBLISHED FOR OPPOSITION
- 07 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Sept 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER